<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shree Ganesh Bio-Tech (India) Limited has submitted a disclosure to BSE, Metropolitan Stock Exchange, and Calcutta Stock Exchange clarifying that it does not qualify as a 'Large Corporate' under SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. The circular pertains to fund raising through issuance of debt securities by large entities. As the company does not fall under the Large Corporate category, it is not required to furnish Initial and Annual Disclosure for the financial year ended March 31, 2026. The filing is dated April 23, 2026, and signed by Aman Patel, Whole-time Director.
This is a routine compliance filing confirming the company is exempt from enhanced disclosure norms applicable to large corporates. No direct impact on shareholders or stock price expected.